Physician profile
Ammar Hashmi
NPI 1871903492
$5,435.50
in general payments reported to CMS, 2019-2025
37 companies · $1,475 in 2025
The $1,475 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,643 · 2020: $375 · 2021: $250 · 2022: $244 · 2023: $33.52 · 2024: $1,415 · 2025: $1,475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,918 · Travel and Lodging: $5.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,917.83 |
| Travel and Lodging | $5.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $1,953.90 | 2019-2020 | |
| Medtronic, INC. | $332.49 | 2022-2025 | Endurant Iis, Avalus, Venaseal |
| W. L. Gore & Associates, INC. | $310.54 | 2024-2025 | Gore Viabahn Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Gore Viabahn Vbx Balloon Expandable Endo |
| Boston Scientific Corporation | $294.18 | 2019-2025 | Enroute Transcarotid Neuroprotection System, Varithena Administration Pack, Ranger |
| Bard Peripheral Vascular, INC. | $251.54 | 2021-2022 | |
| Baxter Healthcare | $187.63 | 2024-2025 | Preveleak |
| Inari Medical, INC. | $182.61 | 2021 | |
| Bone Support INC. | $152.51 | 2024 | Ceramentbone Void Filler, Cerament G |
| Cook Medical LLC | $147.81 | 2025 | Zilver Ptx |
| Surmodics, INC. | $126.34 | 2024-2025 | Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight, Pounce Thrombectomy System |
| Acera Surgical, INC. | $126.10 | 2024-2025 | Restrata Wound Matrix |
| Lemaitre Vascular, INC. | $115.96 | 2025 | Artegraft Vascular Graft, Hydro Lemaitre Valvulotome |
| Endologix LLC | $115.70 | 2025 | Endocross Device, Torus Stent Graft System |
| Cvrx, INC. | $114.68 | 2024 | Barostim Neo System |
| Penumbra, INC. | $106.19 | 2024 | Indigo System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon US, LLC | $105.85 | 2024-2025 | Vistaseal, Evarrest, Stratafix |
| Mindray Ds USA, INC. | $94.33 | 2024 | Te X, Te7 Max |
| Shockwave Medical, INC | $89.75 | 2022-2025 | |
| Aroa Biosurgery Incorporated | $65.95 | 2025 | |
| Bolton Medical INC | $64.57 | 2024-2025 | Treo Abdominal Stent-Graft System |
| Solventum Corporation | $56.27 | 2024-2025 | V.A.C. Veraflo, Activ.A.C., V.A.C.Ulta |
| Silk Road Medical, INC. | $56.01 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Tactile Systems Technology INC | $45.31 | 2025 | Nimbl, Flexitouch Plus |
| Abiomed | $44.86 | 2025 | |
| Becton, Dickinson and Company | $40.80 | 2024 | Progel Applicator Spray Tips |
| Octapharma USA, INC. | $30.84 | 2025 | Fibryga |
| Livanova USA, INC. | $28.81 | 2024 | Protekduo |
| Edwards Lifesciences Corporation | $24.66 | 2025 | Sapien 3 Ultra Resilia |
| Argon Medical Devices, INC. | $22.64 | 2025 | Clot Management |
| Enablecv INC. | $21.53 | 2025 | |
| Philips North America LLC | $20.79 | 2023 | |
| Dilon Technologies, INC. | $20.40 | 2025 | Hemoblast Bellows |
| Veryan Medical Incorporated | $19.60 | 2025 | Biomimics 3d Vascular Stent System |
| Cagent Vascular INC | $18.88 | 2025 | Serrantor |
| Ossur Americas, INC. | $17.55 | 2025 | |
| On Target Laboratories, INC | $15.19 | 2025 | Cytalux |
| Pfizer INC. | $12.73 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ammar Hashmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.